Clinical trials
Phase 3 Vision Disorders trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
18 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2019 | 4 |
| 2020 | 5 |
| 2021 | 2 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 8 |
| Terminated | 6 |
| Recruiting | 4 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Kodiak Sciences Inc | 6 |
| Novartis Pharmaceuticals | 4 |
| Jaeb Center for Health Research | 2 |
| Hoffmann-La Roche | 1 |
| Laboratoires Thea | 1 |
| National Eye Institute (NEI) | 1 |
| Oculis | 1 |
| Opus Genetics, Inc | 1 |
| Thomas Jefferson University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Vision Disorders | 18 |
| Eye Diseases | 9 |
| Retinal Diseases | 9 |
| Retinal Degeneration | 7 |
| Diabetic Retinopathy | 5 |
| Macular Edema | 5 |
| Macular Degeneration | 4 |
| Vision, Low | 4 |
| Retinal Vein Occlusion | 3 |
| Choroidal Neovascularization | 2 |
Trials
Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.